These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 19569602)
1. [Keratoconjunctivitis sicca--an entity underassessed, underdiagnosed and undertreated]. Potop V Oftalmologia; 2009; 53(1):39-45. PubMed ID: 19569602 [TBL] [Abstract][Full Text] [Related]
2. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients. Lee HK; Ryu IH; Seo KY; Hong S; Kim HC; Kim EK Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211 [TBL] [Abstract][Full Text] [Related]
3. Advances in the diagnosis and management of keratoconjunctivitis sicca. Pflugfelder SC Curr Opin Ophthalmol; 1998 Aug; 9(4):50-3. PubMed ID: 10387469 [TBL] [Abstract][Full Text] [Related]
4. Suspected keratitis sicca in a Syrian hamster. Atkinson M Vet Rec; 2000 Jun; 146(23):680. PubMed ID: 10883864 [No Abstract] [Full Text] [Related]
5. Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: a comparison with cyclosporine A. Ofri R; Lambrou GN; Allgoewer I; Graenitz U; Pena TM; Spiess BM; Latour E Vet J; 2009 Jan; 179(1):70-7. PubMed ID: 17950639 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of dry eyes. Wright M; Dhillon B Practitioner; 1997 Apr; 241(1573):210-2, 214, 216. PubMed ID: 9206292 [No Abstract] [Full Text] [Related]
7. Primary Sjögren syndrome: an update on current pharmacotherapy options and future directions. Brito-Zerón P; Sisó-Almirall A; Bové A; Kostov BA; Ramos-Casals M Expert Opin Pharmacother; 2013 Feb; 14(3):279-89. PubMed ID: 23346917 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus dacryoadenitis resulting in keratoconjunctivitis sicca in a child. Merayo-Lloves J; Baltatzis S; Foster CS Am J Ophthalmol; 2001 Dec; 132(6):922-3. PubMed ID: 11730660 [TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of soft contact lenses in severe keratoconjunctivitis sicca treated with local immunosuppressive therapy]. Safonova TN; Gladkova OV; Boev VI; Fedorov AA Vestn Oftalmol; 2016; 132(5):39-48. PubMed ID: 27911424 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of adjunctive therapy using Vizoovet in improving clinical signs of keratoconjunctivitis sicca in dogs: A pilot study. Dees DD; Kent MS Vet Ophthalmol; 2020 Jul; 23(4):632-639. PubMed ID: 32386123 [TBL] [Abstract][Full Text] [Related]
12. [Eledoisin eyedrops in the therapy of keratoconjunctivitis sicca]. Spinelli D; Trabucchi P; Formenti F Ophtalmologie; 1988; 2(2):145-7. PubMed ID: 3247153 [No Abstract] [Full Text] [Related]
13. Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies. Malhotra R; Devries DK; Luchs J; Kabat A; Schechter BA; Shen Lee B; Shettle L; Smyth-Medina R; Ogundele A; Darby C; Bacharach J; Karpecki P Cornea; 2019 Oct; 38(10):1259-1265. PubMed ID: 31306284 [TBL] [Abstract][Full Text] [Related]
14. [Piroxicam eyedrops in keratoconjunctivitis sicca. A new therapeutic perspective]. Bragliani G; Franco F; Marescotti A; Gaiba G Ophtalmologie; 1988 Oct; 2(4):359-62. PubMed ID: 3247209 [No Abstract] [Full Text] [Related]
15. Topical fibronectin in the treatment of keratoconjunctivitis sicca. Chiron Keratoconjunctivitis Sicca Study Group. Nelson JD; Gordon JF Am J Ophthalmol; 1992 Oct; 114(4):441-7. PubMed ID: 1415455 [TBL] [Abstract][Full Text] [Related]
16. Understanding dry eye disease: a managed care perspective. Fiscella RG Am J Manag Care; 2011 Dec; 17 Suppl 16():S432-9. PubMed ID: 22435675 [TBL] [Abstract][Full Text] [Related]
17. Guidelines for the treatment of chronic dry eye disease. Sheppard JD Manag Care; 2003 Dec; 12(12 Suppl):20-5. PubMed ID: 14723110 [TBL] [Abstract][Full Text] [Related]
18. Bilateral keratoconjunctivitis sicca in a horse. Reilly L; Beech J Equine Vet J; 1994 Mar; 26(2):171-2. PubMed ID: 8575385 [No Abstract] [Full Text] [Related]
19. [Instillation of 0.1% hyaluronic acid in severe keratitis sicca]. Tabatabay C J Fr Ophtalmol; 1985; 8(6-7):513. PubMed ID: 4078229 [No Abstract] [Full Text] [Related]
20. Evaluation of a physiological tear substitute in patients with keratoconjunctivitis sicca. Nelson JD; Drake MM; Brewer JT; Tuley M Adv Exp Med Biol; 1994; 350():453-7. PubMed ID: 8030518 [No Abstract] [Full Text] [Related] [Next] [New Search]